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Abstract: The intensive use of pesticides has led to their increasing presence in water, soil,
and agricultural products. Mounting evidence indicates that some pesticides may be endocrine
disrupting chemicals (EDCs), being therefore harmful for the human health and the environment.
In this study, three pesticides, glyphosate, thiacloprid, and imidacloprid, were tested for their
ability to interfere with estrogen biosynthesis and/or signaling, to evaluate their potential action
as EDCs. Among the tested compounds, only glyphosate inhibited aromatase activity (up to 30%)
via a non-competitive inhibition or a mixed inhibition mechanism depending on the concentration
applied. Then, the ability of the three pesticides to induce an estrogenic activity was tested in
MELN cells. When compared to 17β-estradiol, thiacloprid and imidacloprid induced an estrogenic
activity at the highest concentrations tested with a relative potency of 5.4 × 10−10 and 3.7 × 10−9,
respectively. Molecular dynamics and docking simulations predicted the potential binding sites and
the binding mode of the three pesticides on the structure of the two key targets, providing a rational
for their mechanism as EDCs. The results demonstrate that the three pesticides are potential EDCs as
glyphosate acts as an aromatase inhibitor, whereas imidacloprid and thiacloprid can interfere with
estrogen induced signaling.
Keywords: aromatase; estrogen receptor; endocrine disrupting chemical; pesticides; neonicotinoids;
estrogenic activity; gene reporter assay; MELN allosteric inhibition; molecular dynamics
1. Introduction
Under the modern lifestyle, humans are exposed to various chemicals such as pesticide residuals
in fruits and vegetables, antibiotics in meat and milk, preservatives in cosmetics and personal care
products [1,2]. These chemicals are usually in low doses and may not have a short term significant
impact on the human body, but they can cause long term damages to health [3]. The effects of low-dose
compounds on human health are mainly related to the endocrine system [4–6]. These compounds can
in fact mimic or influence the action of endogenous hormones through various mechanisms, being
therefore referred to as endocrine disrupting chemicals (EDCs) [7,8].
The modern industrial and agricultural system relies heavily on pesticides. The compelling need
of high food crop increasingly demands the use of chemicals. This results in the extensive applications
of millions of tons of pesticides every year [9,10]. Among the many pesticides available on the market,
glyphosate is one of the most widely used herbicides in the world. In plants, it affects the synthesis
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of essential aromatic amino acids by inhibiting the activity of 5-enolpyruvylshikimate-3-phosphate
synthase (EPSPS) in the shikimate pathway [11]. As a result, glyphosate is considered harmless to
mammals since they do not contain the EPSPS enzyme [12]. Conversely, neonicotinoids are currently
the most widely used agricultural insecticides [13]. These selective insecticides specifically bind to
the α -subunit of nicotinic acetylcholine receptors (nAChR), which is common in all insects [14,15].
Due to their difficulty to penetrate the blood-brain barrier, they should exert low toxicity in vertebrates.
However, different direct, indirect, and suspect toxic effects of these compounds on vertebrate wildlife
and human health have been reported [16–18]. Neonicotinoids were introduced in the market in
the 1990s, therefore their sales volume has enormously proliferated in recent decades, exceeding
25% of the market in 2010 [19]. Imidacloprid has become the world’s best-selling insecticide next
to glyphosate [20]. Although the European Union banned the outdoor application of imidacloprid,
clothianidin, and thiamethoxam in 2018 due to a high risk for bees that are responsible for pollinating
most crops worldwide [21], neonicotinoids remain the most extensively applied insecticides in the
world [22].
The intensive use of glyphosate-based herbicides and neonicotinoid insecticides has caused the
contamination of soil, water, air, and agricultural products [23–28]. The half-life of glyphosate in the
field is usually 47 days and it is primarily degraded into aminomethylphosphonic acid (AMPA) and
glyoxylic acid by soil microorganisms [29]. Neonicotinoids can exist for a long time in soil and water,
and their half-life being as long as three years [22]. Given these observations and the increased use of
pesticides, concerns are raising about their potential impact on human health and the environment.
In particular, mounting evidence discloses that exposure to pesticides can affect the endocrine system.
Toxicological and epidemiological studies indicate possible genotoxic and cytotoxic effects as well as
birth defects and neurotoxicity in different cell lines and animal models [18,30].
Aiming at establishing the interference of pollutants with human health, we monitored the effect
of glyphosate and two neonicotinoids on two critical targets of the endocrine system: Aromatase,
the enzyme responsible for estrogen biosynthesis, and estrogen receptor (ER) alpha, the main protein
promoting estrogen signaling.
Aromatase catalyzes the transformation of androgens to estrogens [31]. In vitro experiments
showed that glyphosate causes changes of aromatase mRNA levels and activity in placental JEG3 cells
and human HEK293 cells, thus interfering with steroid conversion to estradiol [32,33]. In addition,
the expression of androgen and ERα was inhibited in glyphosate treated HepG2 cells [34,35] where
also the transcription and activity of aromatase were altered [35]. Insecticides such as thiacloprid,
thiamethoxam, and imidacloprid affect aromatase expression and activity in a co-culture model of
fetoplacental steroidogenesis, increasing estrone and estradiol production, while estriol production is
decreased [36]. Thiacloprid, imidacloprid, and thiamethoxam have also been demonstrated to increase
aromatase expression and activity in H295R and Hs578t cells [37,38].
Here, a recombinant form of human aromatase is used to test the possible effect of the three
pesticides on estrogen biosynthesis, gaining new information at molecular level [39–41]. Moreover,
all-atom molecular dynamics simulations provided structural insights on the ability of these molecules
to target the aromatase enzyme.
At a cellular level, the estrogen-regulated signaling is mainly due to estrogen receptors (ERs).
The main ERs are the ERα and ERβ nuclear receptors and the G-protein-coupled estrogen receptor
1, which is a membrane receptor [42]. Estrogen receptor α (ERα) is a nuclear hormone receptor and
a ligand-regulated transcription factor, which mediates the activity of estrogens in vital processes
(i.e., reproduction, cardiovascular maintenance, bone density/remodeling). ERα is composed of five
functional domains, among which the ligand-binding domain, activated upon estrogen binding,
stimulates cell growth and proliferation. After the menopause, increased estrogen levels due to a
deregulated activity of aromatase bind as an agonist to ERα, exerting a pro-oncogenic effect by either
decreasing apoptosis or promoting cell proliferation [43]. Therefore, estrogen selective modulators
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have been developed and one of them, tamoxifen, is extensively used in adjuvant therapy of breast
cancer for its ability to act as an ERα antagonist.
Previous studies have investigated the ability of glyphosate to induce an estrogenic activity
mediated by ERs. The results of the study of Thongprakaisang et al., 2013 [44] demonstrated
that glyphosate induces an ER-mediated estrogenic activity, mediated by ER activation, similar to
17β-estradiol (E2) on T47D-KBluc cells. However, recently another study, using the same cells, showed
that this pesticide induces an estrogenic activity, mediated by ER activation, lower than E2 and that this
activation is probably induced by a ligand-independent mechanism [45]. Moreover, additional studies
on different transfected cells showed that glyphosate did not induce any ER-mediated estrogenic
activity and did not produce any anti-estrogenic effect when tested in combination with E2 [35,46].
Therefore, whether glyphosate can trigger an ER-mediated estrogenic activity remains controversial.
To our knowledge, only three studies have been performed on the estrogenic activity of imidacloprid
and thiacloprid. In particular, in the study of Mesnage et al., 2018 [47] the proliferative effect of both
pesticides was investigated on estrogen-sensitive cells, while Kojima et al., 2004 [46] and Westlund
and Yargeau, 2017 [48] assessed the ER-mediated estrogenic activity of imidacloprid and thiacloprid
on mammalian or yeast cells, respectively. The results of the three studies demonstrated that the two
pesticides induce no proliferative effect and no estrogenic activity was mediated by ERs, while an
anti-estrogenic activity was detected testing imidacloprid in combination with E2 on yeast cells.
In this work, in order to increase the knowledge on the estrogenic activity of glyphosate,
imidacloprid, and thiacloprid, the gene reporter assay on estrogen-sensitive human breast cancer
MCF-7 cells transfected with the ERE-βGlob-Luc-SVNeo plasmid (MELN cells) is applied to test the
three pesticides for their possible ER-mediated estrogenic activity.
Possible additive and/or antagonist effects are also investigated. Moreover, docking simulations
provide atomic level insights on the potential binding mode of these molecules to the primary ligand
(estrogen) binding site as well as to a peripheral allosteric site which may be responsible for the
experimental observed additive effect of the pollutant with the endogenous ligand.
2. Materials and Methods
2.1. Materials
All reagents are analytically pure by purchase from Sigma-Aldrich (St. Louis, MO, USA). Stock
solutions of chemical compounds were prepared in absolute ethanol or dimethyl sulfoxide (DMSO). Before
each experiment, the test sample was diluted into a fresh buffer solution, and the final organic solvent
concentration was less than 0.1%. The recombinant human aromatase (Aro) and the human recombinant
cytochrome P450 reductase (hCPR) were expressed and purified as previously described [39,49].
2.2. ELISA Assay
An estrone direct competitive ELISA kit (BioVendor, Brno, Czech Republic) was used to evaluate
the effect of pesticides on aromatase activity. Different reaction mixtures were set up by mixing 5 nM Aro,
5 nM hCPR, 0.5 mM NADPH, 50 nM androstenedione, and three concentrations of pesticides (500, 1000,
and 1500 nM) in a 100 mM potassium buffer (KPi) containing 20% glycerol, 1 mM β-mercaptoethanol
at pH 7.0. Reactions were carried out for 10 min at 30 ◦C, heat-inactivated for 10 min at 90 ◦C,
and centrifuged for 10 min at 11,000 rpm. After centrifugation, the supernatant was diluted 1:8 in
the Calibrator A provided by the ELISA kit and the product estrone quantified performing ELISA
according to the manufacturer’s instructions. Reactions in the presence of anastrozole or without hCPR
were used as negative controls. The concentration of estrone was extrapolated from a calibration curve
with known concentrations of estrone.
For the experiment where the catalytic parameters were derived, four substrate concentrations
were applied in the reaction mixture (ranging from 25 to 250 nM) in the absence and presence of 1000
and 5000 nM of glyphosate.
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2.3. Computational Studies
In order to explain the molecular terms for the action of glyphosate on the aromatase enzyme
we docked it into the two possible allosteric sites previously identified [50]. Docking has been
performed with the GLIDE software, release 2020-1 (Schrödinger, LLC, New York, NY, USA) using the
single-precision protocol [51]. The two neonicotinoids, thiacloprid and imidacloprid, were instead
docked into the ERαs active site, using as a starting structure the crystal structure of 17-β-estradiol
(EST)-bound ERα dimer (PDB id: 1qku) [52]. In this structure, we have searched for putative allosteric
pockets using the SiteMap algorithm [53].
In order to account for its flexibility of the receptor and since is flexibility resulted to be of
paramount importance for the identification of novel allosteric inhibitors [54], we performed classical
Molecular Dynamics (MD) simulations on the complex with the aromatase enzyme. We employed
as a starting structure of our simulation the equilibrated enzyme model which was embedded in a
mimic of a membrane bilayer by using the CHARMMGUI webserver [55]. This consisted of POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and 6 wt% of cholesterol (CHL) in order to mimic the
endoplasmic reticulum membrane. Physiological protonation states were calculated with the webserver
H++ [56]. Asp309 was considered in its neutral form consistently with other literature studies [57].
The glyphosate molecule was considered in the most likely protonation state at physiological pH.
According to literature data, the first protonation of the molecule occurs on its phosphate group [58].
The Parm99SB AMBER force field (FF) [59,60] and lipid14 FF [61] were used for the protein and
the lipids, respectively.
The Shahrokh et al. parameters were used for the heme moiety and Cys437 [62]. Simulations were
done in the presence of the substrate androstenedione (ASD) in the active site and of glyphosate in the
allosteric pockets for which the general Amber FF (GAFF) was employed [63]. For the organic ligands
the electrostatic potential (ESP) charges [64] were calculated by performing geometry optimization of
the substrates at the Hartree-Fock level of theory using a 6-31G* basis set with the Gaussian 09 software
(Gaussian Inc., Wallingford, CT, USA) [65]. These were later transformed in RESP charges by using the
Antechamber tool [66].
The system was then explicitly solvated using the TIP3P water model, leading to a total of 131,454
atoms. Topology, built with AmberTools 18, was later converted in a GROMACS format using the
acpype algorithm [67]. MD simulations were performed with GROMACS 5.0.4 [68]. An integration
time step of 2 fs was used and all covalent bonds involving hydrogen atoms were constrained with the
LINCS algorithm. The Particle Mesh Ewald algorithm [69] was used in order to account for electrostatic
interactions. Simulations were done in the isothermal-isobaric NPT ensemble, at a temperature of 300 K,
using a velocity-rescaling thermostat [70]. Preliminary energy minimization was done with the steepest
descend algorithm.
An initial equilibration of the membrane was performed for 100 ns with the protein atoms
harmonically restrained with a force constant of 1000 kJ mol−1 nm−2, reaching a constant value (92 ×
92 × 151 Å3) of the simulation box size. Constraints were then slowly released, and the system was
thermalized to the target temperature of 300 K in about 10 ns. Then, the aromatase in complex with
glyphosate was relaxed by performing a 100 ns MD simulation rescaling the motion of the center of
mass of aromatase and the ligand, followed by an unbiased 100 ns MD simulation.
2.4. MELN cell Culture
MELN cells were provided by Dr. P. Balaguer (INSERM, Montpellier, France). They are
estrogen-sensitive human breast cancer cells (MCF-7) transfected with the ERE-βGlob-Luc-SVNeo
plasmid (ERE-βGlob-Luc-SVNeo) [71,72]. The integrated plasmid contains a luciferase reporter gene,
the estrogen-responsive elements (ERE) and an antibiotic resistance selection gene (SVNeo). MELN
cells were cultured at 37 ◦C and 5% CO2 in Dulbecco’s Modified Eagle’s Medium Nutrient Mixture
F12-Ham (DMEM-F12), supplemented with phenol red, fetal bovine serum (FBS) (5% v/v), l-glutamine
(4 mM), penicillin-streptomycin (100 U/mL–100 µg/mL), and G418 (1 mg/mL).
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2.5. MELN Gene Reporter Assay
The assay was carried out as described by Balaguer et al., 1999 [73] with slight modifications [74].
For three days the cells were adapted to a test medium: DMEM-F12 without phenol red
and supplemented with dextran-coated charcoal-treated FBS (5% v/v), l-glutamine (4 mM),
and penicillin-streptomycin (100 U/mL-100 µg/mL). Then, the cells were seeded at a density of
40,000 cells/well, in 96-well plates (100 µL/well). After 24 h, the test medium of each well was replaced
with a test medium containing pesticides (100 µL/wells), and the cells were incubated for 16 h. After the
incubation, the luciferase activity was assessed adding 100 µL/well of the One Glo Reagent (One-Glo
Luciferase Assay System, Promega, Madison, USA), mixing (5 min) and measuring the luminescence
of each well by a luminometer (Infinite Reader M200 Pro, Tecan, Männedorf, Switzerland).
The stock solutions of thiacloprid and imidacloprid were prepared in DMSO, while the stock
solution of glyphosate was prepared in a test medium. The stock solutions were stored at −20 ◦C
and, shortly before exposure, different concentrations of pesticides were prepared in a test medium
(glyphosate and imidacloprid: From 10−8 to 10−3 M; thiacloprid from 10−8 to 5 × 10−4 M, due to lower
solubility). The final DMSO concentration was less than 0.1%. Cells exposed to the test medium were
used as a negative control and five concentrations of E2 (from 10−12 to 10−8 M) were tested to obtain a
standard positive curve of the reference compound (E2).
The estrogenic activity was calculated as the ratio of the activity induced by the treatment over
the activity induced by the positive control with 17-βestradiol (E2). It was expressed in percentage
considering the relative luciferase activity of E2 (10−8 M) as 100%. Since all experiments were performed
in quadruplicate (four wells for each experimental condition), the estrogenic activity was expressed
as the mean and standard deviation of four values. The estrogenic activity of pesticides was also
evaluated by the determination of the relative potency of each pesticide in comparison with the
reference compound (E2) and it was expressed as the E2 equivalency factor (EEF) [75]. The EEF was
calculated using the concentrations of E2 and pesticides at which 50% of biological effect is achieved
(EC50) through the formula: EEF = E2 EC50/pesticide EC50.
Three concentrations of pesticides (10−5, 2.5 × 10−4, and 5 × 10−4 M) were also tested:
In combination with an ER-antagonist (tamoxifen 10−6 M), in order to confirm whether the observed
effects were due to the ER activation, and in combination with E2 (10−10 M), in order to investigate the
interaction between pesticides and E2 in MELN cells. The estrogenic activity of these treatments was
expressed as relative luciferase activity and it was calculated as percentage of activity induced by the
treatment with respect to the activity induced by the E2 10−10 M (relative luciferase activity of E2 10−10
M = 100%). The stock solutions of E2 and tamoxifen were prepared in ethanol and stored at −20 ◦C.
2.6. Data Analysis
Statistical analysis was performed using IBM SPSS Statistics 25.0 (IBM, Armonk, USA). The EC50
of E2 and pesticides was calculated by dose–response curves, which were estimated through a probit
regression between the relative luciferase activity and Log transformed-concentrations of E2 or pesticides.
Data collected with the MELN gene reporter assay were not normally distributed, so the non-parametric
Kruskal-Wallis test followed by the post-hoc Dunnett test was used to assess significant differences among
the different experimental conditions. The differences were considered significant with p-value < 0.05.
3. Results
3.1. Effect of Pesticides on Aromatase Activity
In order to study the effect of pesticide compounds on aromatase activity, a direct competitive
estrone ELISA was performed using the purified cytochrome P450 reductase (CPR), as an electron
donor from NADPH, and aromatase. The aromatase activity was evaluated by measuring the estrone
production in the absence and presence of three different concentrations of pesticides (0.5, 1, and 5 µM).
As a control, anastrozole, a known aromatase inhibitor, was applied at a concentration of 1000 nM
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and the residual aromatase activity detected was 0.7%. As can be seen in Table 1, glyphosate partially
reduced the aromatase activity at the concentrations tested. The enzyme activity decreased with the
increase of glyphosate concentration. When adding 5 µM of glyphosate, the residual aromatase activity
was 36%. Unlike glyphosate, imidacloprid and thiacloprid did not inhibit the enzyme activity (Table 1).
Table 1. Effect of pesticides on the aromatase activity.
Pesticide
Relative Activity (%)
500 nM 1000 nM 5000 nM
1 Glyphosate 76.6 ± 11.3 * 74.5 ± 7.6 * 36.0 ± 19.5 *
2 Imidacloprid 100.1 ± 8.8 92.9 ± 28.0 120.5 ± 17.6
3 Thiacloprid 100.9 ± 11.9 153.6 ± 56.9 146.9 ± 42.1
Statistical significance *: p-value < 0.05 versus positive control (C+).
3.2. Effect of Glyphosate Concentration on Aromatase Activity
The effect of glyphosate on aromatase activity was further studied by exploring the concentration
range of glyphosate applied from 50 to 1500 nM. Such concentrations of glyphosate were selected since
they resemble the ones detected in human urine samples [76]. The experiment was carried out by the
ELISA assay at the concentration of 50 and 400 nM androstenedione, respectively. The two different
concentrations were chosen on the basis of the kinetic parameters of aromatase: The first one (50 nM)
is close to the enzyme KM and the second one (400 nM) is saturating the enzyme (see next paragraph).
As shown in Figure 1, the activity of Aro is inhibited by 30% when the glyphosate concentration
is ≥1000 nM. However, when the substrate concentration is 50 nM (black squares in Figure 1),
the maximal inhibitory effect is already achieved when the glyphosate concentration is 100 nM.
Therefore, the inhibitory effect of glyphosate strongly depends on the substrate concentration and it is
only partial, indicating that this compound can be considered as a weak inhibitor.
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Figure 1. Aromatase activity in the presence of different concentrations of glyphosate and 50 nM
(black squares) or 400 nM (red circles) of the substrate androstenedione. Statistical significance
*: p-value < 0.05 versus C+.
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3.3. Effect of Glyphosate on the Catalytic Parameters of Aro
In order to investigate the mechanism of aromatase inhibition by glyphosate, the kinetic parameters
of the enzyme were evaluated using the estrone ELISA assay in the absence and presence of two
different concentrations of the pesticide (1000 and 5000 nM). Different substrate concentrations were
applied and the product formation rate was plotted as a function of the substrate concentration
(Figure 2A). The plot showed hyperbolic trends and the catalytic parameters, shown in Table 2, were
obtained by fitting the experimental data to the Michaelis-Menten equation.
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Figure 2. (A) Michaelis-Menten plots and (B) Lineweaver-Burk linearization for aromatase activity
in the absence (black circles) and presence of 1000 nM (red squares) and 5000 nM (blue triangles) of
glyphosate. In Panel (A), the data were fitted to the Michaelis-Menten equation using the Sigma Plot
software to obtain the kinetic parameters.
When glyphosate is not present, the resulting KM and Vmax are 41.3 ± 8.2 nM and 0.018 ± 0.001 min−1,
respectively. When 1000 nM of glyphosate was added, the Vmax value was significantly decreased whereas
the KM value as not significantly affected. Interestingly, when the glyphosate concentration was increased
to 5000 M, both KM and Vmax were affected. Compared to the reaction without glyphosate, KM was
increased by 2.2 folds, while Vmax w ecreased to 0.011 ± 0.002 min−1 (Tabl 2).
Table 2. Kinetic parameters obtained from the fitting of the data in Figure 2A to a Michaelis-Menten
curve. The k tic ara eters are calculated for aromatase activity in the absence and pr sence of 1000
and 5000 nM of glyphosate.
Glyphosate (nM) KM (nM) Vmax (min−1)
0 41.3 ± 8.2 0.018 ± 0.001
1000 35.3 ± 3.5 0.013 ± 0.001 *
5000 92. ± 20.7 * 0.011 ± 0.002 *
Statistical significance*: p-value < 0.05 versus the values obtained in the absence of glyphosate.
The kinetic parameters show that the type of inhibition of aromatase by glyphosate depends
on the herbicide concentration applied. Inde d, w en using 1000 nM of glyphosate, the Vmax was
decreased while KM did not change, indicating a non-competitive inhibition mechanism, meaning
that, at this concentration, glyphosate does not compete with the substrate and binds to a site
different from that where the substrate binds. When the concentration of glyphosate was increased
to 5000 nM, both KM and Vmax were affected, and the Lineweaver-Burk plot shows a trend typical
of a mixed inhibition mechanism (Figure 2B). Mixed inhibition is considered a more general case of
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non-competitive inhibition, in which the inhibitor exhibits unequal affinity for the free enzyme and for
the enzyme-substrate complex.
3.4. Molecular Dynamics Simulations on Aromatase
Grounding on recent evidence demonstrating the existence of allosteric binding sites [50] and their
possible exploitation for a non-competitive/mixed inhibition mechanism [54] we docked glyphosate
into the two allosteric cavities. Namely, we docked it to Site 1, which lies along the most relevant
access channel to the enzyme active site [77] and to Site 2, which instead lies at the interface with the
cytochrome P450 reductase (CPR), supplying the electrons necessary for catalysis (Figure 3) [78]. In the
docking pose in Site 1 and during MD simulations glyphosate engages a salt bridge interaction with its
phosphate group and Arg192, as well as the formation of a hydrogen (H)-bond between Gln218 and
the carboxylic group of the pesticide. Most importantly, the phosphate group of glyphosate makes up
to two simultaneous H-bonds with Asp309 (Figure 3), which normally is engaged in stabilizing the
binding of aromatase substrates.
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androste edione (ASD) are displayed in a vdw representation. The protein is shown as green new
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as obtained from the most representative cluster of the molecular dynamics simulation trajectory.
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Due to these interactions the molecule remains stably bound in the pocket for the whole MD
simulation, in lin with its inhibitory activity in the µM range. Remarkably, it was recently suggested
that the bi ding of a small molecule in Site 1 triggered the displacement of the ter molecule ne d
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for the catalytic activity, which are normally H-bonding with the Asp309 and Arg192 residues, both
being critical residues for the catalytic activity [41,57], thus inhibiting estrogen biosynthesis. Conversely,
the docking pose obtained in Site 2, did not establish any relevant H-bond/salt bridge. As a result,
the glyphosate dissociated from the pocket within the first few ns of MD simulations.
3.5. Detection of Estrogenic Activity with the MELN Gene Reporter Assay
The MELN gene reporter assay was carried out to evaluate the estrogenic activity of glyphosate,
imidacloprid, and thiacloprid on MELN cells. In this study, different concentrations of each pesticide
were tested. Concentrations similar to the pesticide levels measured in human urine [76] were selected
as the lowest concentrations (10−8 and 10−7 M), while concentrations up to 10−3 M were selected as
the highest concentrations, in order to assess the effect induced by each pesticide in a wide range
of concentrations.
Our results showed that glyphosate did not increase the relative luciferase activity with respect to
the negative control; therefore no estrogenic activity was detected testing this pesticide on MELN cells
(Figure 4). On the contrary, the highest concentrations of glyphosate induced a small decrease of the
relative luciferase activity, which may be due to a toxic effect of the pesticide on cells.
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Figure 4. Estrogenic activity of pesticides measured with the MELN gene reporter assay. Data are
expressed as means and standard deviations of the relative luciferase activity (% of C+, E2 10−8 M).
The relative luciferase activity of the C+ is 100.0 ± 5.9%, while the relative luciferase activity of the
negative control (test medium) is 30.5 ± 1.1%.
The null estrogenic activity induced by glyphosate was confirmed also by the exposure of cells
to glyphosat i combination with amoxifen (ER-antagonist) or with E2. Indeed, the w lls treated
with glyphosate and tamoxifen sho ed a relativ luciferase activity equal to the w lls treated with
tamoxifen a one, and the wells treated with glyphosat and E2 howed a r lative luciferase activity
equal to the wells treated with E2 a one (data not shown). These results suggest that glyphosate does
not interfere with the binding between ER and E2.
Regarding the neonicotinoid p sticides, in the present study, imidacloprid and thiacloprid
significantly increased the relative luciferas act vity with r s ect to the negative control, starting from
6.3 × 10−5 M (Log[nM] = 4.79) and 10−6 M (Log[nM] = 3), respectively (Kruskal-Wallis test followed by
the post-hoc Dunnett test, p < 0.05). Since both the neonicotinoid pesticides induced a dose-dependent
increase f the rela ive luciferase activity, in particular from 10−4 M (Log[nM] = 5) t the highest tested
dose (Figure 4), a signifi ant estrogenic activity of the two pest cides was detected on ELN cells.
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The estrogenic activity of imidacloprid and thiacloprid was also quantitatively evaluated by the
estimate of the concentrations of E2 and pesticides at which 50% of biological effect is achieved (EC50)
and the E2 equivalency factor (EEF). The EC50 of E2 and pesticides was calculated by dose-response
curves whereas the EEF was calculated through the formula: EEF = E2 EC50/pesticide EC50. The EC50
of imidacloprid and thiacloprid was 1.0 × 10−2 M (IC 95% 1.7 × 10−3–2.2 × 10−1 M) and 1.5 × 10−3 M
(IC 95% 2.5 × 10−4–3.6 × 10−2 M), respectively, while the EEF was 5.4 × 10−10 (IC 95% 3.3 × 10−9–2.5 ×
10−11) and 3.7 × 10−9 (IC 95% 2.2 × 10−8–1.5 × 10−10), respectively.
The exposure of cells to imidacloprid and thiacloprid in combination with tamoxifen confirmed
that the estrogenic activity of the two pesticides was induced by the activation of ER. Indeed, the wells
treated with the neonicotinoid pesticides and tamoxifen showed a relative luciferase activity that was
lower compared to the wells treated with these pesticides alone. Furthermore, the relative luciferase
activity of wells treated with the neonicotinoid pesticides and tamoxifen was similar to the relative
luciferase activity measured in the negative control (Figure 5A,C).
Finally, the exposure of cells to imidacloprid and thiacloprid in combination with E2 induced
an increase of the relative luciferase activity with respect to the E2 alone (Figure 5B,D). The increase
was slight for imidacloprid while it was stronger for thiacloprid, suggesting a possible additive effect
exerted by these pesticides in combination with E2.
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Figure 5. Estrogenic activity, measured with the MELN gene reporter assay, of imidacloprid (A,B) and
thiacloprid (C,D) in combination with E2 (10−10 M) (B,D) or in combination with tamoxifen (10−6 M)
(A,C). Data are expressed as the relative luciferase activity (% of E2 10−10 M). C−: Negative control; E2:
E2 10−10 M; T: Tamoxifen 10−6 M. * p < 0.05 vs. C−; # p < 0.05 vs. E2; Kruskal-Wallis test followed by
the post-hoc Dunnett test.
3.6. Docking Calculation on ERα
In order to provide a rationale for the estrogenic activity exerted by the two neonicotinoids,
thiacloprid and imidacloprid, we have performed docking calculations on ERα. First, the two molecules
were docked into the ERαs estrogen binding site, using the crystal structure of 17-β-estradiol bound to
the ERα dimer (PDB id: 1qku) [52]. Both neonicotinoids fit inside the estrogen binding pocket (Figure 6).
In particular, imidacloprid forms a H-bond with the backbone of Gly521, while in thiacloprid, the Cl
atom makes halogen bonds with the guanidinium group of Arg394 and the aromatic rings of Phe404
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and Trp393. Halogen bonds are attractive interactions between the electrophilic region associated with
the Cl halogen atom and the nucleophilic regions of the surrounding protein residues [79].
Next, in order to disclose if and how the two neonicotinoids exert an additive effect to estrogen
binding, by occupying an allosteric cavity, we looked for the presence of druggable allosteric pockets
in the protein. Interestingly, a high-ranking binding pocket was found in the proximity of the estrogen
binding site of one monomer of ERα (Figure 6). The docking calculation performed on this pocket,
strikingly revealed that imidacloprid can H-bond with Lys449 and Glu323. As well thiacloprid H-bonds
with Lys449 and Trp393.
Int. J. Environ. Res. Public Health 2020, 17, x 12 of 18 
 
3.6. Docking Calculation on ERα 
In order to provide a rationale for the estrogenic activity exerted by the two neonicotinoids, 
thiacloprid and imidacloprid, we have performed docking calculations on ERα. First, the two 
molecules were docked into the ERαs estrogen binding site, using the crystal structure of 17-β-
estradiol bound to the ERα dimer (PDB id: 1qku) [52]. Both neonicotinoids fit inside the estrogen 
binding pocket (Figure 6). In particular, imidacloprid forms a H-bond with the backbone of Gly521, 
while in thiacloprid, the Cl atom makes halogen bonds with the guanidinium group of Arg394 and 
the aromatic rings of Phe404 and Trp393. Halogen bonds are attractive interactions between the 
electrophilic region ssociated w th the Cl halogen atom and the nucleophili  r gions of the 
surrou ding protein residues [79]. 
Next, in or er t  disclose if and how the two neonicotinoids exert an additive eff ct to strogen 
binding, by occupying an allosteric cavity, we lo ked fo  the presence of druggable allosteric pockets 
in he protein. Interestingly, a hi h-ranking binding p cket was found in the proximity of the 
estrogen binding site of one monomer of ERα (Figure 6). The docking calculati  performed on this 
pocket, strikingly revealed that imidacloprid can H-bond with Lys449 and Glu323. As well 
thiacloprid H-bonds with Lys449 and Trp393. 
 
Figure 6. Model of estrogen receptor α dimer (PDB ID 1qku [52]) in complex with the neonicotinoids, 
imidacloprid and thiacloprid. The allosteric pocket is shown as a green transparent surface. 
Imidacloprid, thiacloprid, and 17-β-estradiol are displayed in a van der Waals representation and 
colored by the atom name. The protein is shown as violet new cartoons. The insets report a close view 
of docking poses of imidacloprid and thiacloprid inside the estrogen binding site (red circles) and 
onto the newly identified allosteric pocket (dark blue circles). The ligand and the residues establishing 
the most important interactions are depicted in balls and sticks and licorice representations, 
respectively, and colored by the atom name. 
4. Discussion 
Figure 6. Model of estrogen receptor α dimer (PDB ID 1qku [52]) in complex with the neonicotinoids,
imidacloprid and thiacloprid. The allosteric pocket is shown as a green transparent surface.
Imidacloprid, thiacloprid, and 17-β-estradiol are displayed in a van der Waals representation and
colored by the atom name. The protein is shown as violet new cartoons. The insets report a close view
of docking poses of imidacloprid and thiacloprid inside the estrogen binding site (red circles) and onto
the newly identified allosteric pocket (dark blue circles). The ligand and the residues establishing the
most important interactio s are depicted in balls and sticks and licoric representations, resp ctively,
and color d by the atom name.
4. Discussion
In this study, the effect of three pesticides on two key targets of the endocrine system was
evaluated using a combination of experimental and in silico methods that allowed an investigation at
the molecular level.
The first target considered was aromatase, the key enzyme for estrogen production that resulted in
being partially inhibited by glyphosate. The increase obtained in the aromatase activity in the presence
of imidacloprid and thiacloprid, even if not statistically significant, can be interesting to be further
investigated. Indeed, these two compounds could directly act on aromatase as allosteric activators or
they could exert their action indirectly on CPR that has an essential role in catalysis and acts as an
effector on human aromatase conformation [80,81].
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Glyphosate is the most widely used active compound among herbicides and was already reported
to affect aromatase expression and activity in cells [33,35]. The impact for human health has already
been demonstrated: Indeed, an alteration in androgens/estrogens balance due to a lower aromatase
expression as a consequence of the glyphosate presence changed the sperm nuclear quality impacting
mammalian reproduction [82].
However, the direct interaction between glyphosate and the enzyme together with the inhibition
mechanism was not reported yet. In this study, the ELISA assay revealed that the inhibition of
aromatase by glyphosate is partial and weak and strongly depends on the substrate concentration.
Moreover, at the lower concentration of glyphosate tested (1 µM), the inhibition was found to be
non-competitive, while at the higher concentration used (5 µM), the inhibition turned into a mixed
inhibition mode. These data suggest that glyphosate binds to an allosteric site both when the enzyme
is free and in complex with the substrate. Classical MD simulations supply a structural model for
glyphosate binding to aromatase, explaining at the atomic-level that this pollutant may exert its
inhibitory activity at a low concentration by binding to the allosteric Site 1 previously identified by
Magistrato et al. [50] and demonstrated to bind small-molecules inhibitors [54]. When the concentration
increases, a mixed inhibition is observed again compatible with the presence of an allosteric site.
The binding of glyphosate probably becomes stronger or another allosteric site is occupied by the
inhibitor. However, MD simulations showed that glyphosate did not stably bind to the second allosteric
pocket (Site 2) identified in previous studies.
The second important target studied was the estrogen receptor that is responsible for estrogen
binding and signal transduction in cells. MCF-7 cells, stably transfected with an estrogen-regulated
luciferase gene (MELN cells), were used to assess the estrogenic activity of the pesticides. Glyphosate
induced no estrogenic activity on MELN cells, moreover glyphosate did not change the effect induced by
tamoxifen or E2. These results are in accordance with the results of the studies of Kojima et al., 2004 [46]
and Gasnier et al., 2009 [35], who did not find any agonistic or antagonistic effect of glyphosate on
ER. On the contrary, our results are different than the results of Thongprakaisang et al., 2013 [44] and
Mesnage et al., 2017 [45] who found a significant increase of ER-induced estrogenic activity. A possible
explanation of this discrepancy could be that in our study the estrogenic activity was evaluated on
MELN cells while the other two studies applied T47D-KBluc cells, which might be more sensitive
to the glyphosate activity than MELN cells. Moreover, our results are consistent with the results of
the Endocrine Disruptor Screening Program (EDSP) conducted by the United States Environmental
Protection Agency (US EPA, 2015) which concluded that “there is no convincing evidence of a potential
interaction with the estrogen pathway for glyphosate”.
In the present study, both imidacloprid and thiacloprid induced a dose-response estrogenic
activity mediated by the ER activation, in particular starting from 10−4 M. A consistent result was
found in the study of Kojima et al., 2004 [46] in which no estrogenic activity was detected exposing
transfected-cells to imidacloprid at concentrations lower than 10−5 M; a contradicting result was found
by Westlund and Yargeau, 2017 [48], who did not find any estrogenic activity testing thiacloprid
at concentrations comparable to ours. The conflicting results of thiacloprid should be interpreted
considering the different cell models applied in our study with respect to the study of Westlund
and Yargeau, 2017 (i.e., the present study was performed on mammalian cells while the previous
one on yeast cells) [48]. Indeed, yeast cells are characterized by a different membrane permeability,
transport proteins, and signal transduction pathways with respect to mammalian cells which may
have influenced the results [42], as reported before also for other nuclear receptors [83].
The estrogenic activity of imidacloprid and thiacloprid was observed at concentrations higher
than the pesticide levels measured in human biological samples [76,84]. Although such high levels
of pesticides are not found in human biological samples, low doses of these pesticides should not
be considered harmless. Indeed, in biological fluids these pesticides may be present in combination
with other EDCs with a similar action mode and, thus, these pesticides together with other EDCs
might cause an overall estrogenic effect. Moreover, these high concentrations of pesticides are similar
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to levels in some environmental matrices, where they could cause adverse health effects on wildlife
animals. For example, in guttation water or morning dew of plants, imidacloprid was found to be
present at a concentration up to 346 mg/L [85].
Interestingly, the results of the present study showed that, when the ER-antagonist tamoxifen was
added to these pesticides, the estrogenic activity was still higher than the negative control. This result
can be explained by the competition between each pesticide and tamoxifen for ER binding. Moreover,
in the presence of high concentrations of imidacloprid and thiacloprid, an additive effect with E2 was
also observed. The docking calculation suggested that these two neonicotinoids may bind to both
the orthosteric and allosteric pockets of ERα, suggesting a putative mechanism to rationalize their
observed estrogenic activity.
5. Conclusions
In conclusion, this study provides further evidence about the action of some pesticides as endocrine
disrupting chemicals (EDCs) targeting important proteins of the endocrine system. In particular,
it shows that the inhibitory effects of the three compounds tested on aromatase are partial and their
estrogenic effects occur at relatively high concentrations. However, possible additive estrogenic
effects with the physiological hormone 17-βestradiol are present. Furthermore, it has to be taken into
account that pesticides are usually introduced in the environment with their co-formulants that can
be also biologically active as EDCs. Previous studies already showed that aromatase is inhibited by
co-formulants of glyphosate-based herbicides [33,86]. Moreover, more studies are needed to investigate
a possible additive effect of different pesticides that can be contemporarily present in the environment.
Our study also provides an integrated approach based on different assays and computational
methods that allowed gaining new information about the possible interaction of pesticides and key
targets at a molecular level. Such information can be exploited to predict the possible impact of other
compounds on estrogen production and signaling in order to develop safer compounds for human
health and environment.
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